Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies-Reference-Cited by-同舟云学术

Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies

Published:2023-05-18 Issue:2 Volume:92 Page:97-105
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Boulter Alexis C.,Maurer Barry J.,Pogue Meredith,Kang Min H.,Cho Hwangeui,Knight Amanda,Reynolds C. Patrick,Quick Donald,Awasthi Sanjay,Gerber David E.^ORCID

Funder

National Cancer Institute

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Cancer Prevention and Research Institute of Texas

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-023-04543-6.pdf

Reference35 articles.

1. Siddique MM, Li Y, Chaurasia B, Kaddai VA, Summers SA (2015) Dihydroceramides: from bit players to lead actors. J Biol Chem 290(25):15371–15379

2. Lachkar F, Ferré P, Foufelle F, Papaioannou A (2021) Dihydroceramides: their emerging physiological roles and functions in cancer and metabolic diseases. Am J Physiol Endocrinol Metab 320(1):E122-e130

3. Chan LN, Zhang S, Shao J, Waikel R, Thompson EA, Chan TS (1997) N-(4-hydroxyphenyl) retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells. Leuk Lymphoma 25(3–4):271–280

4. Di Vinci A, Geido E, Infusini E, Giaretti W (1994) Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. Int J Cancer 59(3):422–426

5. Kalemkerian GP, Ou X (1999) Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines. Cancer Chemother Pharmacol 43(2):145–150

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingolipid metabolism and regulated cell death in malignant melanoma;Apoptosis;2024-07-28